The short version of Angiotensin IV analog fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-03-21 and is reviewed periodically as new material appears.
Dihexa is not approved as a medicine in major regulatory jurisdictions. It is commonly sold as a research chemical for laboratory use, though such products may not be standardized or independently verified. Scientific literature on dihexa includes in vitro assays, rodent studies, and reviews that discuss its proposed mechanism. The distinction between peer-reviewed findings and commercial promotion is important when evaluating available information. Open questions include its precise binding interactions, pharmacokinetics, and whether animal results translate to human biology.
Dihexa is a synthetic peptide derived from angiotensin IV, a naturally occurring fragment of the renin-angiotensin system. Researchers modified the angiotensin IV structure to improve metabolic stability and central nervous system activity. It is frequently described as a hepatocyte growth factor mimetic because it can activate the c-Met receptor pathway in experimental systems. Its development reflects interest in small peptides that influence synaptic plasticity and cognitive processes. Most information comes from preclinical studies rather than controlled human trials.
The compound has been examined in animal models for effects on learning, memory, and synaptic connectivity. Some reports describe increased dendritic spine density and improved performance on certain behavioral tasks after administration in rodents. These findings are often cited in discussions of nootropic research peptides, but replication across independent laboratories remains limited. The absence of published phase 1 or phase 2 clinical trial data makes it difficult to assess safety, effective routes, or long-term outcomes in humans. Consequently, claims about cognitive benefits in people remain speculative.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide | Derived from angiotensin IV and modified for stability. |
| Proposed mechanism | c-Met/HGF pathway activation | Described as an HGF mimetic in experimental systems. |
| Common synonyms | Dihexa; N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Name usage varies by supplier and publication. |
| Regulatory status | Not approved as a drug | Sold as a research chemical in some markets. |
| Human trial data | Limited or absent | Most evidence comes from preclinical studies. |
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
=== H. G. Wells === Author H. G. Wells was born in Bromley on 21 September 1866, to Sarah and Joseph Wells; his father was the founder of the Bromley Cricket Club and the proprietor of a shop that sold cricket equipment. Wells spent the first 13 years of his life in Bromley. From 1874 to 1879 he attended Tomas Morley's Bromley Academy, at 74 High Street. There was a 'H. G. Wells Centre' in Masons Hill near the southern end of the High Street which housed the Bromley Labour Club (the building was demolished in 2017). In August 2005, the wall honouring Wells in Market Square was repainted; the current wall painting features a rich green background with the same Wells reference and the evolutionary sequence of Homo sapiens featured in Origin of Species by Charles Darwin, a former resident of nearby Downe Village. Wells wrote about Bromley in an early unsigned article in the Pall Mall Gazette in which he expressed satisfaction that he had been born in an earlier, more rural Bromley. A blue plaque marks Wells' birthplace in Market Square, on the wall of what is now a Primark store. A marble plaque appears above the door of 8 South Street, the location of Mrs Knott's Dame school where "Bertie", as he was called as a child, learned to read and write. H. G. Wells featured Bromley in two of his novels: The War in the Air (which refers to Bromley as Bunhill) and The New Machiavelli (in which Bromley is referred to as Bromstead). However, H. G.
== Reaction == In the catalytic cycle, the immediate one-electron oxidized product is monodehydroascorbate (MDHA). MDHA is either enzymatically reduced back to ascorbate by monodehydroascorbate reductase (MDAR) or two MDHA molecules disproportionate to ascorbate and dehydroascorbate (DHA).
Myoglobin and hemoglobin, the first two proteins whose structures were solved by X-ray crystallography, have very similar folds made up of about 70% α-helix, with the rest being non-repetitive regions, or "loops" that connect the helices. In classifying proteins by their dominant fold, the Structural Classification of Proteins database maintains a large category specifically for all-α proteins. Hemoglobin then has an even larger-scale quaternary structure, in which the functional oxygen-binding molecule is made up of four subunits.
=== Technology === When considering food storage and preservation, the technologies of modified atmosphere and controlled atmosphere are widely used for the storage and packing of several types of foods. They offer several advantages such as delay of ripening and senescence of horticultural commodities, control of some biological processes such as rancidity, insects, bacteria and decay, among others. Controlled atmosphere (CA) storage refers to atmospheres that are different than normal air and strictly controlled at all times. This type of storage manipulates the CO2 and O2 levels within airtight stores of containers. Modified atmosphere (MA) storage refers to any atmosphere different from normal air, typically made by mixing CO2, O2, and N2.
== Etymology == The origin of the gly- and glu- prefixes for glycols and sugars is from Ancient Greek γλυκύς glukus which means sweet. Glycérine was coined c. 1811 by Michel Eugène Chevreul to denote what was previously called "sweet principle of fat" by its discoverer Carl Wilhelm Scheele. Chevreul's term was borrowed into English c. 1838, and during the 20th century it was displaced by an 1872 term glycerol that incorporates the -ol suffix common to alcohols.
Sources: en.wikipedia.org
== Awards and honors == Distinguished Mentor Award (University of Utah) 2019 University of Utah MUSE Professor 2019-ongoing Presidential Scholar Award (University of Utah) 2016–2019 Teva Pharmaceutical Scholar Award 2015–2018 Young Investigator Award, Metals in Medicine Gordon Conference 2012 Fellow of the American Association for the Advancement of Science 2023
=== Daniel Van Deventer === Daniel Van Deventer (Alex Akpobome), nicknamed “DVD,” is a Pierpoint trader transferred from New York to London during plans to consolidate the two offices. A former protégé of Eric Tao, DVD’s rapid rise places him in direct competition with Eric, ultimately contributing to Eric’s demotion after the loss of Felim Bichan as a client. DVD assumes Eric’s responsibilities as CPS MD and begins a sexual relationship with Harper, encouraging her to consider relocating to New York as the London office faces closure. He later suspends Harper after secretly listening in on a call in which she helps Jesse Bloom unload positions at Pierpoint’s expense. DVD grows disillusioned with Pierpoint after being instructed by Adler to ignore Nicole Craig’s sexual assault of Venetia Berens, and sympathizes with Harper upon learning she was also assaulted by Nicole. He agrees to leave the firm with Harper, Eric, and Rishi, but is ultimately betrayed when Harper and Eric strike a deal with Adler to preserve a reduced London operation by branding DVD and Rishi as disloyal. DVD is fired along with much of the London office, discovering his dismissal only when his security badge stops working.
=== Sequencing and synthesis === The sequence of the oligonucleotide selected using SELEX is determined with the help of DNA sequencing. This information is used for the synthesis of the oligonucleotide's enantiomer, the L-RNA aptamer, using L-nucleotides.
Through the early stages of the game, Combine Civil Protection units pursue Gordon Freeman, the player character, through City 17 after Gordon's presence is mistakenly revealed to Dr. Breen. Due to Gordon's actions in Half-Life and his subsequent disappearance, which earned him a legendary reputation, Dr. Breen sees Gordon as a significant threat. As Gordon flees the city, Civil Protection units raid the resistance base of Black Mesa East and capture resistance leader Eli Vance, who is transferred to holding facilities at Nova Prospekt. Gordon, along with Eli's daughter Alyx, breaks into the facility to rescue him, but Eli is teleported to the Combine Citadel by double agent Judith Mossman. The strike against Nova Prospekt prompts a revolution by the citizens of Earth and heavy street fighting takes place. In Episode One, the destruction of the teleporter has isolated Combine forces on Earth, and its primary reactor has begun to melt down. This forces Gordon and Alyx to journey back into the critically damaged Citadel to stabilize its reactor while the city's inhabitants are evacuated. The Combine forces, however, instead attempt to accelerate the meltdown in order to contact their native dimension for reinforcements. After Alyx acquires an encrypted copy of the message to be sent, Overwatch forces desperately attempt to stop the pair from escaping the city, spurred on by Combine Advisors. As the pair escape on a train at the end of the game, the Citadel detonates and destroys City 17.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide derived from angiotensin IV and studied for effects on synaptic plasticity. It is often described as a hepatocyte growth factor mimetic. It is not an approved medication.
It is based on angiotensin IV, a naturally occurring peptide fragment, but dihexa itself is chemically modified and synthetic. The modifications aim to improve stability and activity compared with the parent fragment.
Laboratory studies have used cell-based assays and rodent models. These examine receptor signaling, dendritic spine changes, and behavioral tasks. Published human clinical trial data are lacking.
The lyophilized powder is generally stored at -20 °C or lower, desiccated, and protected from light. Solutions are often aliquoted to avoid repeated freeze-thaw cycles. Specific stability data may vary by formulation and purity.